Inga Back, MPH

Researchers evaluated the effect of statin use on risk for cardiovascular disease, all-cause mortality, and type 2 diabetes in patients with rheumatoid arthritis.

Based on results from the ORAL Surveillance trial, researchers of this study assessed the risk for cardiovascular outcomes with tofacitinib in patients with rheumatoid arthritis.

Researchers assessed the effect of an online osteoarthritis weight program on physiotherapists’ self-reported confidence in their knowledge and skills in weight management and their attitude toward obesity.

Researchers assessed and compared the clinical efficacy of romosozumab in patients with rheumatoid arthritis osteoporosis and primary osteoporosis.

In a poster presented at ASBMR 2021, researchers compared fracture rates and treatment adherence in women with osteoporosis who received risedronate gastro-resistant vs oral immediate-release bisphosphonates.

Researchers identified trajectories of depression and comorbidity in patients with knee osteoarthritis, and described the characteristics of distinctive trajectories.

In a meta-analysis, researchers investigated the effectiveness of exercise therapy on muscle mass gain in patients with rheumatoid arthritis and identified the factors for treatment efficacy in muscle mass gain.

The AHA has issued a Presidential Advisory Statement outlining considerations for addressing the effects of opioids on cardiovascular and neurovascular health.

Researchers studied the effect of apremilast on body weight and composition, glucose homeostasis, lipid profiles, and vascular function in psoriatic disease.

Researchers assessed the use of repurposed and adjuvant drugs in hospitalized patients with COVID-19 across 3 continents.